A prospective randomized study on the mobilization of CD34+ cells comparing continuous intravenous vs subcutaneous administration of rhG-CSF in normal donors

K. E. Lee, Y. C. Mun, S. H. Nam, J. M. Kwon, S. M. Lee, M. A. Lee, E. S. Yoo, J. Y. Ahn, Jae-Hong Kim, C. M. Seong

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The efficacy of mobilizing peripheral blood progenitor cells (PBPC) with continuous intravenous (c.i.v.) administration of rhG-CSF was randomly compared to subcutaneous (s.c.) administration, in 15 normal donors in each arm of the study for 6 days. The percentage and absolute numbers of CD34+ cells in the c.i.v. and s.c. groups increased maximally at day 3 and 5, respectively, when compared with the steady-state (day 0) level. Peak CD34+ cell levels were achieved on day 3 in the c.i.v. group, with more rapid results than in the s.c. group (49.3/ μl vs 35.9/μl, P = 0.043). Plasma rhG-CSF levels declined progressively during mobilization in each group as the WBC increased. The serum level of rhG-CSF did not correlate with CD34+ cell counts in the peripheral blood. Toxicity profiles in the c.i.v. and s.c. groups were similar. Each regimen was effective in successfully mobilizing the target CD34 cell number.

Original languageEnglish
Pages (from-to)1027-1031
Number of pages5
JournalBone Marrow Transplantation
Volume36
Issue number12
DOIs
Publication statusPublished - 2005 Dec 1

Fingerprint

Cell Count
Prospective Studies
Intravenous Administration
Blood Cells
Stem Cells
Serum

Keywords

  • CD34 cells
  • Continuous IV rhG-CSF
  • Mobilization
  • Normal individuals

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

A prospective randomized study on the mobilization of CD34+ cells comparing continuous intravenous vs subcutaneous administration of rhG-CSF in normal donors. / Lee, K. E.; Mun, Y. C.; Nam, S. H.; Kwon, J. M.; Lee, S. M.; Lee, M. A.; Yoo, E. S.; Ahn, J. Y.; Kim, Jae-Hong; Seong, C. M.

In: Bone Marrow Transplantation, Vol. 36, No. 12, 01.12.2005, p. 1027-1031.

Research output: Contribution to journalArticle

Lee, K. E. ; Mun, Y. C. ; Nam, S. H. ; Kwon, J. M. ; Lee, S. M. ; Lee, M. A. ; Yoo, E. S. ; Ahn, J. Y. ; Kim, Jae-Hong ; Seong, C. M. / A prospective randomized study on the mobilization of CD34+ cells comparing continuous intravenous vs subcutaneous administration of rhG-CSF in normal donors. In: Bone Marrow Transplantation. 2005 ; Vol. 36, No. 12. pp. 1027-1031.
@article{1fa0e510e0e84a6bbfa42a7c46596d5f,
title = "A prospective randomized study on the mobilization of CD34+ cells comparing continuous intravenous vs subcutaneous administration of rhG-CSF in normal donors",
abstract = "The efficacy of mobilizing peripheral blood progenitor cells (PBPC) with continuous intravenous (c.i.v.) administration of rhG-CSF was randomly compared to subcutaneous (s.c.) administration, in 15 normal donors in each arm of the study for 6 days. The percentage and absolute numbers of CD34+ cells in the c.i.v. and s.c. groups increased maximally at day 3 and 5, respectively, when compared with the steady-state (day 0) level. Peak CD34+ cell levels were achieved on day 3 in the c.i.v. group, with more rapid results than in the s.c. group (49.3/ μl vs 35.9/μl, P = 0.043). Plasma rhG-CSF levels declined progressively during mobilization in each group as the WBC increased. The serum level of rhG-CSF did not correlate with CD34+ cell counts in the peripheral blood. Toxicity profiles in the c.i.v. and s.c. groups were similar. Each regimen was effective in successfully mobilizing the target CD34 cell number.",
keywords = "CD34 cells, Continuous IV rhG-CSF, Mobilization, Normal individuals",
author = "Lee, {K. E.} and Mun, {Y. C.} and Nam, {S. H.} and Kwon, {J. M.} and Lee, {S. M.} and Lee, {M. A.} and Yoo, {E. S.} and Ahn, {J. Y.} and Jae-Hong Kim and Seong, {C. M.}",
year = "2005",
month = "12",
day = "1",
doi = "10.1038/sj.bmt.1705186",
language = "English",
volume = "36",
pages = "1027--1031",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - A prospective randomized study on the mobilization of CD34+ cells comparing continuous intravenous vs subcutaneous administration of rhG-CSF in normal donors

AU - Lee, K. E.

AU - Mun, Y. C.

AU - Nam, S. H.

AU - Kwon, J. M.

AU - Lee, S. M.

AU - Lee, M. A.

AU - Yoo, E. S.

AU - Ahn, J. Y.

AU - Kim, Jae-Hong

AU - Seong, C. M.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - The efficacy of mobilizing peripheral blood progenitor cells (PBPC) with continuous intravenous (c.i.v.) administration of rhG-CSF was randomly compared to subcutaneous (s.c.) administration, in 15 normal donors in each arm of the study for 6 days. The percentage and absolute numbers of CD34+ cells in the c.i.v. and s.c. groups increased maximally at day 3 and 5, respectively, when compared with the steady-state (day 0) level. Peak CD34+ cell levels were achieved on day 3 in the c.i.v. group, with more rapid results than in the s.c. group (49.3/ μl vs 35.9/μl, P = 0.043). Plasma rhG-CSF levels declined progressively during mobilization in each group as the WBC increased. The serum level of rhG-CSF did not correlate with CD34+ cell counts in the peripheral blood. Toxicity profiles in the c.i.v. and s.c. groups were similar. Each regimen was effective in successfully mobilizing the target CD34 cell number.

AB - The efficacy of mobilizing peripheral blood progenitor cells (PBPC) with continuous intravenous (c.i.v.) administration of rhG-CSF was randomly compared to subcutaneous (s.c.) administration, in 15 normal donors in each arm of the study for 6 days. The percentage and absolute numbers of CD34+ cells in the c.i.v. and s.c. groups increased maximally at day 3 and 5, respectively, when compared with the steady-state (day 0) level. Peak CD34+ cell levels were achieved on day 3 in the c.i.v. group, with more rapid results than in the s.c. group (49.3/ μl vs 35.9/μl, P = 0.043). Plasma rhG-CSF levels declined progressively during mobilization in each group as the WBC increased. The serum level of rhG-CSF did not correlate with CD34+ cell counts in the peripheral blood. Toxicity profiles in the c.i.v. and s.c. groups were similar. Each regimen was effective in successfully mobilizing the target CD34 cell number.

KW - CD34 cells

KW - Continuous IV rhG-CSF

KW - Mobilization

KW - Normal individuals

UR - http://www.scopus.com/inward/record.url?scp=30544446066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=30544446066&partnerID=8YFLogxK

U2 - 10.1038/sj.bmt.1705186

DO - 10.1038/sj.bmt.1705186

M3 - Article

VL - 36

SP - 1027

EP - 1031

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 12

ER -